Access to Rare Indications Act of 2020
Sponsored By: Representative Thompson, Mike [D-CA-4]
Unknown
Summary
Access to Rare Indications Act of 2020 This bill prohibits coverage exclusions or limitations under the Medicare prescription drug benefit, Medicaid, or private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals and that are supported by the National Institutes of Health Rare Diseases Clinical Research Network).
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Thompson, Mike [D-CA-4]
CA • D
Cosponsors
Rep. Kelly, Mike [R-PA-16]
PA • R
Sponsored 9/30/2020
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov